Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma

Cell Reports(2020)10.1016/j.celrep.2020.108293Source: DataRank Database

Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma is a research paper published in Cell Reports (2020). On theSindex it has a DataRank of 0. It has been cited 70 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access70 citations

Download PDF

Cite:

Linked data & code

geo hpa doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: goldTopics (34)IDs (PubMed, PMC)Annotations (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (32)

Emily Z. Keung ORCID,Ming Tang ORCID,Yan Liang ORCID,Hunain Alam ORCID,Guangchun Han ORCID

Live enrichment

PubMed:33086062 PMC:PMC7649750

American Cancer Society

Grant: RSG-15-145-01-CDD

National Cancer Institute

Grant: CA207109

National Cancer Institute

Grant: CA157919

National Cancer Institute

Grant: CA160578

National Cancer Institute

Grant: CA207098

National Cancer Institute

Grant: CA222214

National Cancer Institute

Grant: P30CA016672

NCI NIH HHS

Grant: R01 CA207109

NCI NIH HHS

Grant: R00 CA160578

NCI NIH HHS

Grant: R01 CA207098

NCI NIH HHS

Grant: K99 CA160578

NCI NIH HHS

Grant: R01 CA222214

NCI NIH HHS

Grant: R01 CA157919

University of Texas MD Anderson Cancer Center

National Institutes of Health

goldLicense: cc-by-nc-nd

publisherhttp://www.cell.com/article/S2211124720312821/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124720312821?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124720312821?httpAccept=text/plain

repositoryhttps://doaj.org/article/c36af48cd2dc464096d008d1f2795abf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7649750

MeSH Terms

Cell Line, TumorAnimalsMice, Inbred C57BLHumansMiceMice, NudeMelanomaInsulinHistone-Lysine N-MethyltransferaseReceptor, IGF Type 1GlucoseIntercellular Signaling Peptides and ProteinsCarrier ProteinsDNA-Binding ProteinsNeoplasm ProteinsXenograft Model Antitumor AssaysSignal TransductionRegulatory Sequences, Nucleic AcidGlycolysisGenes, Tumor SuppressorFemaleMaleMyeloid-Lymphoid Leukemia ProteinHistone Methyltransferases

Keywords

MelanomaEpigeneticschromatinglycolysisMouse Model2-DgRnai ScreenIgfbp5Kmt2dLinsitinib

Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma

FAIR Checklist

Authors (32)

Funding (15 grants)

Open Access

Topics

Annotations (Europe PMC)